OLANZAPINE PAMOATE | CHEPLAPHARM | ||
EQ 210MG BASE/VIAL,EQ 300MG BASE/VIAL,EQ 405MG BASE/VIAL | |||
No | No | ||
2018-Sep-30 | Expired | ||
None | 2012-Dec-11 | ||
None | No | ||
ZYPREXA® RELPREVV™ is a long-acting atypical antipsychotic for intramuscular injection indicated for the treatment of schizophrenia. |
0 | 0 | 0 |
Total Other Developers | None |
---|
Drugs with Suitability | No |
---|
EQ 210MG BASE/VIAL | ** | ** | - | - | - |
EQ 300MG BASE/VIAL | ** | ** | - | - | - |
EQ 405MG BASE/VIAL | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
Yes | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com